TW200518774A - Volatile proof solid preparation and producing method thereof - Google Patents

Volatile proof solid preparation and producing method thereof

Info

Publication number
TW200518774A
TW200518774A TW093134088A TW93134088A TW200518774A TW 200518774 A TW200518774 A TW 200518774A TW 093134088 A TW093134088 A TW 093134088A TW 93134088 A TW93134088 A TW 93134088A TW 200518774 A TW200518774 A TW 200518774A
Authority
TW
Taiwan
Prior art keywords
evaporating
volatile
solid preparation
producing method
agent
Prior art date
Application number
TW093134088A
Other languages
English (en)
Chinese (zh)
Other versions
TWI333421B (cg-RX-API-DMAC7.html
Inventor
Nobuo Miyautsu
Toshiakira Horie
Hideyoshi Kanbe
Toshiaki Kurazumi
Teiji Murata
Original Assignee
Ssp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co Ltd filed Critical Ssp Co Ltd
Publication of TW200518774A publication Critical patent/TW200518774A/zh
Application granted granted Critical
Publication of TWI333421B publication Critical patent/TWI333421B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093134088A 2003-11-28 2004-11-09 Volatile proof solid preparation and producing method thereof TW200518774A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003399851A JP5248733B2 (ja) 2003-11-28 2003-11-28 揮散防止型固形製剤およびその製造方法

Publications (2)

Publication Number Publication Date
TW200518774A true TW200518774A (en) 2005-06-16
TWI333421B TWI333421B (cg-RX-API-DMAC7.html) 2010-11-21

Family

ID=34724286

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093134088A TW200518774A (en) 2003-11-28 2004-11-09 Volatile proof solid preparation and producing method thereof

Country Status (4)

Country Link
JP (1) JP5248733B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050052361A (cg-RX-API-DMAC7.html)
CN (1) CN1636553A (cg-RX-API-DMAC7.html)
TW (1) TW200518774A (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5000491B2 (ja) * 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
JP2007131561A (ja) * 2005-11-09 2007-05-31 Ss Pharmaceut Co Ltd 経口固形製剤及びその製造法
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
JP2008127350A (ja) * 2006-11-22 2008-06-05 Ss Pharmaceut Co Ltd 臭いを防止した固形組成物
TWI392505B (zh) * 2006-11-22 2013-04-11 Ssp Co Ltd 固形組合物
CA2671975C (en) * 2006-12-07 2013-10-29 Daiichi Sankyo Company, Limited Film-coated preparation having improved stability
EP2100610A4 (en) 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd PHARMACEUTICAL COMPOSITION WITH LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
KR102209574B1 (ko) * 2019-10-08 2021-02-01 주식회사 에스엔비아 싸이올 화합물 소취용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129138A (ja) * 1984-11-16 1986-06-17 Takeda Chem Ind Ltd 被覆製剤
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
JP2591235B2 (ja) * 1989-03-30 1997-03-19 吉富製薬株式会社 アルキルシステインまたはその酸付加塩を含有する安定な錠剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH0656677A (ja) * 1992-08-03 1994-03-01 Lion Corp 制酸剤組成物
JPH08310953A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形組成物
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung

Also Published As

Publication number Publication date
CN1636553A (zh) 2005-07-13
JP2005162619A (ja) 2005-06-23
KR20050052361A (ko) 2005-06-02
TWI333421B (cg-RX-API-DMAC7.html) 2010-11-21
JP5248733B2 (ja) 2013-07-31

Similar Documents

Publication Publication Date Title
MX2007006084A (es) Composiciones y metodos de recubrimiento.
TW200518774A (en) Volatile proof solid preparation and producing method thereof
CY1109011T1 (el) ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ βd ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΔΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
EP1845095A4 (en) 1-thio-D-GLUCITOLDERIVATE
CA2379614A1 (en) Fragrance emitting device
EP1478322A4 (en) Beta 2'-OR 3'-HALONUCLEOSIDE
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
WO2004084453A3 (en) METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
CA2427988A1 (en) Tobacco odor deodorizing perfume composition, tobacco odor deodorant, cigarette low in sidestream smoke odor, and tobacco package
WO2002016026A3 (en) Adsorbent and/or catalyst compounds promoted with halide ions and methods of making and using thereof
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
MX2007013623A (es) Preparacion externa para la piel.
DK1301077T3 (da) Antimikrobielt præparat, som er nyttigt til behandling af bovin mastitis
WO2006118948A3 (en) Therapeutic compositions
EP1438944A3 (en) Absorbent article with an odor control coating
WO2004047663A3 (en) Oral compositions which mask the salty taste of salts
RU2008112676A (ru) Противоопухолевое средство
ATE296298T1 (de) Duft vorläufer
ATE395908T1 (de) Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
WO2004022699A3 (en) Liquid stable composition of oxazaphosphorine with mesna
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
EP1460123A4 (en) PROCESS FOR AROMA-MAINTENANCE AND APPLICATION THEREOF
WO2003028774A1 (en) Deodorizer, process for producing the same, and method of deodorization
AR050452A1 (es) Derivados de cci-779

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees